Treatment Strategies for Unexplained Infertility

Abstract

Unexplained infertility is a common diagnosis among couples with infertility. Pragmatic treatment options in these couples are directed at trying to improve chances to conceive, and consequently intrauterine insemination (IUI) with ovarian stimulation and in vitro fertilization (IVF) are standard clinical practice, while expectant management remains an important alternative. While evidence on IVF or IUI with ovarian stimulation versus expectant management was inconclusive, these interventions seem more effective in couples with a poor prognosis of natural conception. Strategies such as strict cancellation criteria and single-embryo transfer aim to reduce multiple pregnancies without compromising cumulative live birth. We propose a prognosis-based approach to manage couples with unexplained infertility so as to expose less couples to unnecessary interventions and less mothers and children to the potential adverse effects of ovarian stimulation or laboratory procedures.

Keywords

unexplained infertility - expectant management - intrauterine insemination - in vitro fertilization - cost-effectiveness - safety

Publication History

Article published online:
29 October 2020

• References

• 1 Evers JL. Female subfertility. Lancet 2002; 360 (9327): 151-159
• 2 Eijkemans MJ, van Poppel F, Habbema DF, Smith KR, Leridon H, te Velde ER. Too old to have children? Lessons from natural fertility populations. Hum Reprod 2014; 29 (06) 1304-1312
• 3 van den Boogaard NM, van den Boogaard E, Bokslag A. et al. Patients' and professionals' barriers and facilitators of tailored expectant management in subfertile couples with a good prognosis of a natural conception. Hum Reprod 2011; 26 (08) 2122-2128
• 4 Eijkemans MJ, Lintsen AM, Hunault CC. et al. Pregnancy chances on an IVF/ICSI waiting list: a national prospective cohort study. Hum Reprod 2008; 23 (07) 1627-1632
• 5 Chua SJ, Danhof NA, Mochtar MH. et al. Age-related natural fertility outcomes in subfertile women over 35: an individual participant data meta-analysis. Hum Reprod 2020; 35 (08) 1808-1820
• 6 Hunault CC, Habbema JD, Eijkemans MJ, Collins JA, Evers JL, te Velde ER. Two new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. Hum Reprod 2004; 19 (09) 2019-2026
• 7 van der Steeg JW, Steures P, Eijkemans MJ. et al. CECERM Study Group (Collaborative Effort for Clinical Evaluation in Reproductive Medicine). Pregnancy is predictable: a large-scale prospective external validation of the prediction of spontaneous pregnancy in subfertile couples. Hum Reprod 2007; 22 (02) 536-542
• 8 van Eekelen R, van Geloven N, van Wely M. et al. Constructing the crystal ball: how to get reliable prognostic information for the management of subfertile couples. Hum Reprod 2017; b 32 (11) 2153-2158
• 9 van Eekelen R, Scholten I, Tjon-Kon-Fat RI. et al. Natural conception: repeated predictions over time. Hum Reprod 2017; a 32 (02) 346-353
• 10 van Eekelen R, McLernon DJ, van Wely M. et al. External validation of a dynamic prediction model for repeated predictions of natural conception over time. Hum Reprod 2018; 33 (12) 2268-2275
• 11 Marrero MA, Ory SJ. Unexplained infertility. Curr Opin Obstet Gynecol 1991; 3 (02) 211-218
• 12 Moghissi KS. The function of the cervix in fertility. Fertil Steril 1972; 23 (04) 295-306
• 13 Guttmacher AF. The role of artificial insemination in the treatment of human sterility. Bull N Y Acad Med 1943; 19 (08) 573-591
• 14 Cohlen B, Bijkerk A, Van der Poel S, Ombelet W. IUI: review and systematic assessment of the evidence that supports global recommendations. Hum Reprod Update 2018; 24 (03) 300-319
• 15 Practice Committee of the American Society for Reproductive Medicine. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertil Steril 2020; 113 (02) 305-322
• 16 Hughes E, Brown J, Collins JJ, Vanderkerchove P. Clomiphene citrate for unexplained subfertility in women. Cochrane Database Syst Rev 2010; (01) CD000057
• 17 Bhattacharya S, Harrild K, Mollison J. et al. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial. BMJ 2008; 337: a716
• 18 Irianni FM, Acosta AA, Oehninger S, Acosta MR. Therapeutic intrauterine insemination (TII)--controversial treatment for infertility. Arch Androl 1990; 25 (02) 147-167
• 19 Group ECW. ESHRE Capri Workshop Group. Intrauterine insemination. Hum Reprod Update 2009; 15 (03) 265-277
• 20 Ayeleke RO, Asseler JD, Cohlen BJ, Veltman-Verhulst SM. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev 2020; 3: CD001838
• 21 Ron-El R, Caspi E, Schreyer P, Weinraub Z, Arieli S, Goldberg MD. Triplet and quadruplet pregnancies and management. Obstet Gynecol 1981; 57 (04) 458-463
• 22 Gleicher N, Oleske DM, Tur-Kaspa I, Vidali A, Karande V. Reducing the risk of high-order multiple pregnancy after ovarian stimulation with gonadotropins. N Engl J Med 2000; 343 (01) 2-7
• 23 Dickey RP. Strategies to reduce multiple pregnancies due to ovulation stimulation. Fertil Steril 2009; 91 (01) 1-17
• 24 Danhof NA, Wang R, van Wely M, van der Veen F, Mol BWJ, Mochtar MH. IUI for unexplained infertility-a network meta-analysis. Hum Reprod Update 2020; 26 (01) 1-15
• 25 Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet 1978; 2 (8085): 366
• 26 Pandian Z, Gibreel A, Bhattacharya S. In vitro fertilisation for unexplained subfertility. Cochrane Database Syst Rev 2015; (11) CD003357
• 27 Bensdorp AJ, Tjon-Kon-Fat RI, Bossuyt PM. et al. Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterine insemination with controlled ovarian hyperstimulation. BMJ 2015; 350: g7771
• 28 Custers IM, König TE, Broekmans FJ. et al. Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation. Fertil Steril 2011; 96 (05) 1107-11.e1
• 29 Nandi A, Bhide P, Hooper R. et al. Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial. Fertil Steril 2017; 107 (06) 1329-1335.e2
• 30 Reindollar RH, Regan MM, Neumann PJ. et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertil Steril 2010; 94 (03) 888-899
• 31 Goldman MB, Thornton KL, Ryley D. et al. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T). Fertil Steril 2014; 101 (06) 1574-81.e1 , 2
• 32 Gadalla MA, Wang R, van Wely M, Mol BWJ. How should we report outcomes in reproductive medicine?. Ultrasound Obstet Gynecol 2018; 51 (01) 7-9
• 33 Harbin Consensus Conference Workshop Group, Conference Chairs. Legro RS, Wu X, Barnhart KT, Farquhar C, Fauser BCJM, Mol B. Improving the reporting of clinical trials of infertility treatments (IMPRINT): modifying the CONSORT statement. Hum Reprod 2014; 29 (10) 2075-2082
• 34 Pinborg A, Loft A, Nyboe Andersen A. Neonatal outcome in a Danish national cohort of 8602 children born after in vitro fertilization or intracytoplasmic sperm injection: the role of twin pregnancy. Acta Obstet Gynecol Scand 2004; 83 (11) 1071-1078
• 35 Källén B, Finnström O, Lindam A, Nilsson E, Nygren KG, Otterblad Olausson P. Trends in delivery and neonatal outcome after in vitro fertilization in Sweden: data for 25 years. Hum Reprod 2010; 25 (04) 1026-1034
• 36 Wang R, Seidler AL, Askie L. et al. Network meta-analyses in reproductive medicine: challenges and opportunities. Hum Reprod 2020; 35 (08) 1723-1731
• 37 Wang R, Danhof NA, Tjon-Kon-Fat RI. et al. Interventions for unexplained infertility: a systematic review and network meta-analysis. Cochrane Database Syst Rev 2019; 9: CD012692
• 38 Tjon-Kon-Fat RI, Bensdorp AJ, Scholten I. et al. IUI and IVF for unexplained subfertility: where did we go wrong?. Hum Reprod 2016; 31 (12) 2665-2667
• 39 Danhof NA, van Wely M, Repping S. et al. SUPER Study Group. Follicle stimulating hormone versus clomiphene citrate in intrauterine insemination for unexplained subfertility: a randomized controlled trial. Hum Reprod 2018; 33 (10) 1866-1874
• 40 Wessel JA, Mol F, Danhof NA. et al. Perinatal outcomes of assisted reproduction compared to natural conception in couples with unexplained subfertility - Follow up of two randomized clinical trials. 36th Annual Meeting of ESHRE.. 2020: 780
• 41 Mintjens S, Menting MD, Gemke RJBJ. et al. The effects of intrauterine insemination and single embryo transfer or modified natural cycle in vitro fertilization on offspring's health—follow-up of a randomized clinical trial. Eur J Obstet Gynecol Reprod Biol 2019; 242: 131-138
• 42 Ombelet W, Martens G, Bruckers L. Pregnant after assisted reproduction: a risk pregnancy is born! 18-years perinatal outcome results from a population-based registry in Flanders, Belgium. Facts Views Vis ObGyn 2016; 8 (04) 193-204
• 43 Pandey S, Shetty A, Hamilton M, Bhattacharya S, Maheshwari A. Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis. Hum Reprod Update 2012; 18 (05) 485-503
• 44 Berntsen S, Söderström-Anttila V, Wennerholm UB. et al. The health of children conceived by ART: ‘the chicken or the egg?’. Hum Reprod Update 2019; 25 (02) 137-158
• 45 Tan-Torres Edejer T, Baltussen R, Adam T. et al. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Geneva, Switzerland: World Health Organization; 2003
• 46 Husereau D, Drummond M, Petrou S. et al. CHEERS Task Force. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMJ 2013; 346: f1049
• 47 ESHRE Capri Workshop Group. Economic aspects of infertility care: a challenge for researchers and clinicians. Hum Reprod 2015; 30 (10) 2243-2248
• 48 van Rumste MM, Custers IM, van Wely M. et al. IVF with planned single-embryo transfer versus IUI with ovarian stimulation in couples with unexplained subfertility: an economic analysis. Reprod Biomed Online 2014; 28 (03) 336-342
• 49 Tjon-Kon-Fat RI, Bensdorp AJ, Bossuyt PM. et al. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?. Hum Reprod 2015; 30 (10) 2331-2339
• 50 Danhof NA, van Wely M, Repping S. et al. Amsterdam SUPER Study Group. Gonadotrophins or clomiphene citrate in couples with unexplained infertility undergoing intrauterine insemination: a cost-effectiveness analysis. Reprod Biomed Online 2020; 40 (01) 99-104
• 51 Pham CT, Karnon JD, Norman RJ, Mol BW. Cost-effectiveness modelling of IVF in couples with unexplained infertility. Reprod Biomed Online 2018; 37 (05) 555-563
• 52 van Eekelen R, Eijkemans MJ, Mochtar M. et al. Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?. Hum Reprod 2020; 35 (09) 2037-2046
• 53 Hendriks S, van Wely M, D'Hooghe TM. et al. The relative importance of genetic parenthood. Reprod Biomed Online 2019; 39 (01) 103-110
• 54 Barry MJ, Edgman-Levitan S. Shared decision making--pinnacle of patient-centered care. N Engl J Med 2012; 366 (09) 780-781
• 55 Tucker Edmonds B. Shared decision-making and decision support: their role in obstetrics and gynecology. Curr Opin Obstet Gynecol 2014; 26 (06) 523-530
• 56 Duffy JMN, Bhattacharya S, Curtis C, Evers JLH, Farquharson RG, Franik S. et al. A protocol developing, disseminating and implementing a core outcome set for infertility. Hum Reprod Open 2018; 2018 (03) hoy007